ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly GAAP effective tax rate: 23.3% in Q2 2026, up 6.8 pts from a year earlier.
Latest, Q2 2026
23.3%
Period ended Jun 30, 2026
Change on a year earlier
+6.8 pts
16.5% in Q2 2025
History
30 quarters
Since Q3 2016
Sources
26
Documents cited below
Where the Q2 2026 figure comes from
“|| Effective tax rate - Reported | 23.3 | % | 16.5 | % | 19.9 | % | 17.7 | %”
Source: Earnings Release (Form 8-K FY2026Q2 EX-99.1) (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K MD&A, Note 13 & Form 8-K Earnings Releases.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up GAAP effective tax rate
Cite this data
StockData. (2026). Eli Lilly GAAP effective tax rate (%), quarterly Q3 2016–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/tax-rate-gaap
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.